6533b824fe1ef96bd1281354
RESEARCH PRODUCT
The Fevipiprant Phase IIIb Systemic Corticosteroid Avoidance Study: SHIELD
C. MailaenderWilliam W. BussePablo AltmanSebastian FucileJ. StrigkasK.f. RabeArnaud BourdinS. HiltlRoland BuhlC.b. Pisalsubject
business.industrymedicine.drug_classPhase (matter)AnesthesiaShieldMedicineCorticosteroidFevipiprantbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2019-05-01 | A32. ASTHMA: CLINICAL STUDIES II |